The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 31, 2013
Filed:
Feb. 15, 2010
Alexander Von Gabain, Vienna, AT;
Eszter Nagy, Vienna, AT;
Andreas Meinke, Pressbaum, AT;
Sanja Selak, Vienna, AT;
Markus Hanner, Pressbaum, AT;
Margarita Smidt, Vienna, AT;
Michaela Weissgram, Hinterbruhl, AT;
Birgit Noiges, Vienna, AT;
Stefan Seidel, Wiener Neustadt, AT;
Julia Bacher, Vienna, AT;
Christina Satke, Moedling, AT;
Wolfgang Schueler, Vienna, AT;
Martin Oleksiewicz, Vienna, AT;
Alexander Von Gabain, Vienna, AT;
Eszter Nagy, Vienna, AT;
Andreas Meinke, Pressbaum, AT;
Sanja Selak, Vienna, AT;
Markus Hanner, Pressbaum, AT;
Margarita Smidt, Vienna, AT;
Michaela Weissgram, Hinterbruhl, AT;
Birgit Noiges, Vienna, AT;
Stefan Seidel, Wiener Neustadt, AT;
Julia Bacher, Vienna, AT;
Christina Satke, Moedling, AT;
Wolfgang Schueler, Vienna, AT;
Martin Oleksiewicz, Vienna, AT;
Valneva Austria GmbH, Vienna, AT;
Abstract
The present invention relates to isolated nucleic acid molecules which encode an antigen from a nontypable() species, a vector which comprises such nucleic acid molecule, and a host cell comprising such vector. Furthermore, the invention provides antigens from a nontypablespecies, as well as fragments and variants thereof, a process for producing such antigens, and a process for producing a cell, which expresses such antigen. More specifically such antigens are produced by or associated with bacterial infections caused by nontypable. Moreover, the present invention provides antibodies binding to such antigen, a hybridoma cell producing such antibodies, methods for producing such antibodies, a pharmaceutical composition comprising such nucleic acid molecule, antigen, vector or antibody, the use of such nucleic acid molecule, antigen, vector or antibody for the preparation of a pharmaceutical composition, methods for identifying an antagonist capable of binding such antigen or of reducing or inhibiting the interaction activity of such antigen, methods for diagnosing an infection with nontypableand methods for the treatment or prevention of an infection with nontypable